China – China’s CDE creates COVID-19 vaccine development guidelines

China’s Center for Drug Evaluation (CDE) has published a slate of guidance documents covering different aspects of the research and development of vaccines against the SARS-CoV-2 coronavirus.

The first document presents technical guidelines for the development of COVID-19 vaccines. CDE has also shared four other documents that cover topics such as the guiding principles of mRNA vaccine research and the nonclinical evaluation of COVID-19 prophylactics. The publication of the texts follows the initiation of Phase 3 COVID-19 trials by Chinese companies including Sinopharm..